Search results
Results from the WOW.Com Content Network
Methoxy polyethylene glycol-epoetin beta, sold under the brand name Mircera, is a long-acting erythropoietin receptor activator (CERA) used for the treatment of anaemia associated with chronic kidney disease. [4] It is the first approved, chemically modified erythropoiesis-stimulating agent (ESA). [citation needed]
Mircera. The following types of ESAs are available: [citation needed] Erythropoietin (Epo) Epoetin alfa (Procrit, Epogen) Epoetin beta (NeoRecormon) Epoetin zeta (Silapo, Retacrit) Darbepoetin alfa (Aranesp) Methoxy polyethylene glycol-epoetin beta (Mircera)
n/a n/a Ensembl n/a n/a UniProt n a n/a RefSeq (mRNA) n/a n/a RefSeq (protein) n/a n/a Location (UCSC) n/a n/a PubMed search n/a n/a Wikidata View/Edit Human Erythropoietin (/ ɪ ˌ r ɪ θ r oʊ ˈ p ɔɪ. ɪ t ɪ n, - r ə -, - p ɔɪ ˈ ɛ t ɪ n, - ˈ iː t ɪ n / ; EPO), also known as erythropoetin, haematopoietin, or haemopoietin, is a glycoprotein cytokine secreted mainly by the kidneys ...
For premium support please call: 800-290-4726 more ways to reach us more ways to reach us
Jourdain Solis, 27, of Fresno, California, accepted the buyout because he had heard that the program he works for at the Internal Revenue Service, checking compliance with fuel tax laws, would be ...
The FAA announced in a statement in April 2019, during Trump’s first term in office, that its Office of Civil Rights would look for “specific opportunities for people with targeted ...
Epoetin alfa, sold under the brand name Epogen among others, is a human erythropoietin produced in cell culture using recombinant DNA technology. [ 8 ] [ 9 ] Epoetin alfa is an erythropoiesis-stimulating agent. [ 8 ]
Peginesatide [2] (INN/USAN, trade name Omontys, formerly Hematide), developed by Affymax and Takeda, is an erythropoietic agent, a functional analog of erythropoietin.. It was approved by the U.S. Food and Drug Administration for treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis.